Dietary salt restriction in primary aldosteronism
- PMID: 36945840
- DOI: 10.1111/joim.13625
Dietary salt restriction in primary aldosteronism
Comment on
-
Moderate dietary salt restriction improves blood pressure and mental well-being in patients with primary aldosteronism: The salt CONNtrol trial.J Intern Med. 2023 Jul;294(1):47-57. doi: 10.1111/joim.13618. Epub 2023 Mar 22. J Intern Med. 2023. PMID: 36945842 Clinical Trial.
References
-
- Young WF, Jr. Diagnosis and treatment of primary aldosteronism: practical clinical perspectives. J Intern Med. 2019;285:126-48.
-
- Monticone S, D'Ascenzo F, Moretti C, Williams TA, Veglio F, Gaita F, et al. Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis. Lancet Diabetes Endocrinol. 2018;6:41-50.
-
- Hundemer GL, Curhan GC, Yozamp N, Wang M, Vaidya A. Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study. Lancet Diabetes Endocrinol. 2018;6:51-9.
-
- Muth A, Ragnarsson O, Johannsson G, Wangberg B. Systematic review of surgery and outcomes in patients with primary aldosteronism. Br J Surg. 2015;102:307-17.
-
- Schneider H, Sarkis A-L, Sturm L, Britz V, Lechner A, Potzel aL, et al. Moderate dietary salt restriction improves blood pressure and mental wellbeing in patients with primary aldosteronism: the salt control trial. J Intern Med. 2023;294:47-57.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
